Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-032897

SVP,Clinical & Medical Affairs sold 539,283 shares at an average $2.45 ($1,321,329)

  • SVP,Clinical & Medical Affairs acquired 510,838 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hogge Gary S. · SVP,Clinical & Medical Affairs

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-28 Exercise or conversion : show line 1 in the form +185,000 $0.69 $128,002 213,445 D
2021-12-28 Exercise or conversion : show line 2 in the form +236,899 $2.11 $499,857 450,344 D
2021-12-28 Exercise or conversion : show line 3 in the form +79,689 $1.14 $90,845 530,033 D
2021-12-28 Sale : show line 4 in the form −501,588 $2.45 $1,228,891 28,445 D
2021-12-29 Exercise or conversion : show line 5 in the form +9,250 $0.69 $6,400 37,695 D
2021-12-29 Sale : show line 6 in the form −9,250 $2.49 $23,033 28,445 D
2021-12-29 Sale : show line 7 in the form −28,445 $2.44 $69,406 0 D
Open-market sales · 539,283 sh · avg $2.45 · $1,321,329

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-12-28 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −185,000 259,000 D
2021-12-28 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −236,899 10,301 D
2021-12-28 Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) −79,689 32,811 D
2021-12-29 Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) −9,250 249,750 D
Loading xslF345X03/ownership.xml…